- Investing Ideas
- /
- U.S. High Growth Tech and AI Stocks
U.S. High Growth Tech and AI Stocks
Results
227
Companies within the technology and artificial intelligence (AI) sector, that exhibit significant growth potential, providing opportunities to capitalize on the rapid advancement and innovation within the industry.
227 companies
AVITA Medical
Market Cap: US$152.0m
Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.
RCEL
US$6.11
7D
8.7%
1Y
-33.2%
Ascendis Pharma
Market Cap: US$10.7b
Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally.
ASND
US$173.06
7D
6.3%
1Y
26.2%
Lumentum Holdings
Market Cap: US$5.7b
Manufactures and sells optical and photonic products in the Americas, the Asia-Pacific, Europe, the Middle East, and Africa.
LITE
US$81.46
7D
12.7%
1Y
77.9%
Travere Therapeutics
Market Cap: US$1.3b
A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.
TVTX
US$15.32
7D
2.0%
1Y
114.9%
Alnylam Pharmaceuticals
Market Cap: US$40.2b
Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.
ALNY
US$300.83
7D
-1.2%
1Y
96.9%
Alkami Technology
Market Cap: US$3.1b
Provides cloud-based digital banking solutions in the United States.
ALKT
US$30.46
7D
6.4%
1Y
13.2%
TG Therapeutics
Market Cap: US$5.7b
A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.
TGTX
US$40.06
7D
14.1%
1Y
152.7%
Super Micro Computer
Market Cap: US$24.3b
Develops and sells high performance server and storage solutions based on modular and open architecture in the United States, Europe, Asia, and internationally.
SMCI
US$41.55
7D
3.8%
1Y
-46.0%
Ardelyx
Market Cap: US$870.9m
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.
ARDX
US$3.68
7D
0.3%
1Y
-42.9%
Mereo BioPharma Group
Market Cap: US$391.1m
A biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally.
MREO
US$2.74
7D
27.4%
1Y
-19.9%
Legend Biotech
Market Cap: US$5.8b
Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.
LEGN
US$35.00
7D
20.9%
1Y
-23.2%
Alvotech
Market Cap: US$3.2b
Through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide.
ALVO
US$10.66
7D
-6.8%
1Y
-24.1%
Blueprint Medicines
Market Cap: US$8.3b
A precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally.
BPMC
US$127.85
7D
26.1%
1Y
23.7%
Palantir Technologies
Market Cap: US$283.0b
Palantir Technologies Inc. builds and deploys software platforms for the intelligence community to assist in counterterrorism investigations and operations in the United States, the United Kingdom, and internationally.
PLTR
US$127.72
7D
-3.1%
1Y
447.9%
Madrigal Pharmaceuticals
Market Cap: US$6.1b
A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.
MDGL
US$278.23
7D
1.1%
1Y
13.9%
MeiraGTx Holdings
Market Cap: US$440.4m
A clinical stage genetics medicines company, focusing on developing treatments for patients with serious diseases.
MGTX
US$6.00
7D
17.2%
1Y
25.8%
Soleno Therapeutics
Market Cap: US$3.8b
A clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.
SLNO
US$75.51
7D
2.9%
1Y
65.7%
SpringWorks Therapeutics
Market Cap: US$3.5b
A commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for underserved patient populations suffering from rare diseases and cancer.
SWTX
US$46.80
7D
0.2%
1Y
16.4%
ARS Pharmaceuticals
Market Cap: US$1.3b
A biopharmaceutical company, develops and commercializes treatments for severe allergic reactions.
SPRY
US$14.49
7D
0.4%
1Y
64.5%
OS Therapies
Market Cap: US$45.8m
A clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States.
OSTX
US$1.67
7D
9.2%
1Y
n/a
Achieve Life Sciences
Market Cap: US$122.3m
A clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction.
ACHV
US$3.83
7D
7.0%
1Y
-28.0%
Abeona Therapeutics
Market Cap: US$314.5m
A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.
ABEO
US$6.74
7D
8.0%
1Y
57.8%
Aldeyra Therapeutics
Market Cap: US$146.7m
A biotechnology company, discovers and develops therapies designed to treat immune-mediated and metabolic diseases.
ALDX
US$2.66
7D
23.7%
1Y
-31.1%
Tenaya Therapeutics
Market Cap: US$87.8m
A clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States.
TNYA
US$0.63
7D
37.8%
1Y
-82.6%
Similarweb
Market Cap: US$666.6m
Provides digital data and analytics for power critical business decisions in the United States, Europe, the Asia Pacific, the United Kingdom, Israel, and internationally.
SMWB
US$7.89
7D
6.3%
1Y
2.6%
Roadzen
Market Cap: US$73.1m
Operates as an insurance technology company.
RDZN
US$1.04
7D
5.7%
1Y
-63.4%
Vanda Pharmaceuticals
Market Cap: US$258.7m
A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.
VNDA
US$4.61
7D
6.2%
1Y
-24.7%
SideChannel
Market Cap: US$10.2m
SideChannel, Inc. identifies, develops, and deploys of v solutions in North America.
SDCH
US$0.045
7D
2.3%
1Y
-34.7%
UroGen Pharma
Market Cap: US$237.0m
Engages in the development and commercialization of solutions for urothelial and specialty cancers.
URGN
US$7.37
7D
73.8%
1Y
-44.2%
Capricor Therapeutics
Market Cap: US$602.4m
A clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States.
CAPR
US$14.23
7D
43.9%
1Y
171.6%
Verastem
Market Cap: US$339.6m
A development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States.
VSTM
US$6.42
7D
-14.6%
1Y
88.8%
RenovoRx
Market Cap: US$51.2m
A clinical-stage biopharmaceutical company, engages in the developing of targeted combination therapies to enhance therapeutic outcomes for cancer patients undergoing treatment.
RNXT
US$1.39
7D
-0.7%
1Y
36.3%
TruGolf Holdings
Market Cap: US$9.7m
Through its subsidiary, engages in the design, development, manufacture, and sale of golf simulators for residential and commercial applications in the United States.
TRUG
US$0.23
7D
-3.3%
1Y
-79.0%
Spotify Technology
Market Cap: US$146.2b
Provides audio streaming subscription services worldwide.
SPOT
US$712.26
7D
7.1%
1Y
131.1%
Workday
Market Cap: US$66.8b
Provides enterprise cloud applications in the United States and internationally.
WDAY
US$252.72
7D
2.0%
1Y
17.2%
ACADIA Pharmaceuticals
Market Cap: US$3.6b
A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.
ACAD
US$21.98
7D
1.9%
1Y
47.6%